Johnson & Johnson to Participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC)
Johnson & Johnson JNJ
News
-
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Macatawa Bank Corporation (Nasdaq - MCBC), Shockwave Medical, Inc. (Nasdaq – SWAV), Apartment Income REIT Corp. (NYSE - AIRC), Model N, Inc. (NYSE – MODN)
WHO Likely to Issue Wider Warning About J&J Cough Syrup Contamination, Reuters Reports
Johnson & Johnson's stock falls as profit beats but sales fall slightly short of estimates
Johnson & Johnson on Track for Lowest Close Since November 2020 — Data Talk
CORRECTING and REPLACING Johnson & Johnson Reports Q1 2024 Results
Trending: Johnson & Johnson 1Q Adjust Earnings Beat Forecasts as Company Raises Dividend
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Macatawa Bank Corporation (Nasdaq - MCBC), Shockwave Medical, Inc. (Nasdaq – SWAV), Apartment Income REIT Corp. (NYSE - AIRC), Model N, Inc. (NYSE – MODN)
Johnson & Johnson Raises Quarterly Dividend by 4.2% to $1.24
Johnson & Johnson Announces 62nd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.2%
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Shockwave Medical, Inc. (Nasdaq – SWAV), Apartment Income REIT Corp. (NYSE - AIRC), Model N, Inc. (NYSE – MODN), ARCA biopharma, Inc. (Nasdaq - ABIO)
Johnson & Johnson to Participate in the 2024 RBC Capital Markets Global Healthcare Conference
CARVYKTI® is the First and Only BCMA-Targeted Treatment Approved by the U.S. FDA for Patients with Relapsed or Refractory Multiple Myeloma Who Have Received at Least One Prior Line of Therapy
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Shockwave Medical, Inc.
Trending: Johnson & Johnson Buying Shockwave Medical
J&J to acquire Shockwave Medical in $13.1 billion deal that will boost its heart-disease medtech portfolio
Shockwave Shares Inch Higher Premarket on Takeover by J&J
Johnson & Johnson to Buy Shockwave Medical in $13.1 Billion Deal — 2nd Update
Johnson & Johnson to Buy Shockwave Medical in $13.1 Billion Deal — Update
Johnson & Johnson to Buy Shockwave Medical in $13.1 Billion Deal